|Titre :||Drug misuse: Psychosocial interventions|
|Auteurs :||National Collaborating Centre for Mental Health, Guideline Development Group|
|Type de document :||Rapport|
|Mention d'édition :||National Clinical Practice Guideline No. 51|
|Editeur :||Leicester : British Psychological Society, 2008|
|Format :||338 p.|
|Discipline :||TRA (Traitement et prise en charge / Treatment and care)|
Thésaurus TOXIBASEPRODUIT ILLICITE ; INTERVENTION ; RECOMMANDATION ; PSYCHOSOCIOLOGIE ; METHODE ; TRAITEMENT ; PSYCHOTHERAPIE ; INTERVENTION BREVE ; REDUCTION DES RISQUES ; AUTOSUPPORT ; PRISON ; RECHERCHE
This guideline has been developed to advise on psychosocial interventions for drug misuse. The guideline recommendations have been developed by a multidisciplinary team of healthcare professionals, service users, a carer and guideline methodologists after careful consideration of the best available evidence. It is intended that the guideline will be useful to clinicians and service commissioners in providing and planning high-quality care for people who misuse drugs while also emphasising the importance of the experience of care for people who misuse drugs and their carers.
Although the evidence base is rapidly expanding, there are a number of major gaps, and future revisions of this guideline will incorporate new scientific evidence as it develops. The guideline makes a number of research recommendations specifically to address gaps in the evidence base. In the meantime, it is hoped that the guideline will assist clinicians, people who misuse drugs and their carers by identifying the merits of particular treatment approaches where the evidence from research and clinical experience exists.
|Domaine :||Drogues illicites / Illicit drugs|